BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37074866)

  • 1. Navigating Practice Issues Related to the Unsatisfactory Cervicovaginal Papanicolaou Test: Survey Results of Laboratories Participating in the 2020 College of American Pathologists PAP Education Program.
    Goyal A; Booth CN; Souers RJ; Tabbara SO; Roberson J; Henry MR; Sundling KE; Goodrich K; Nguyen L
    Arch Pathol Lab Med; 2024 Jan; 148(1):48-54. PubMed ID: 37074866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unsatisfactory reporting rates: 2006 practices of participants in the college of american pathologists interlaboratory comparison program in gynecologic cytology.
    Moriarty AT; Clayton AC; Zaleski S; Henry MR; Schwartz MR; Eversole GM; Tench WD; Fatheree LA; Souers RJ; Wilbur DC
    Arch Pathol Lab Med; 2009 Dec; 133(12):1912-6. PubMed ID: 19961244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescreening Practices of Negative Papanicolaou Tests With Positive Human Papillomavirus Test Result.
    Goyal A; Davey DD; Souers RJ; Tabbara SO; Goodrich K; Booth CN
    Arch Pathol Lab Med; 2022 Jan; 146(1):78-83. PubMed ID: 33929528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Papillomavirus Genotyping Testing Practice in 2014: Results of a College of American Pathologists National Survey.
    Zhao C; Crothers BA; Ghofrani M; Li Z; Souers RJ; Hussain M; Fan F; Ocal IT; Goodrich K; Shen R; Davey DD;
    Arch Pathol Lab Med; 2016 Dec; 140(12):1364-1370. PubMed ID: 27479334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bethesda 2014 Implementation and Human Papillomavirus Primary Screening: Practices of Laboratories Participating in the College of American Pathologists PAP Education Program.
    Davey DD; Souers RJ; Goodrich K; Mody DR; Tabbara SO; Booth CN
    Arch Pathol Lab Med; 2019 Oct; 143(10):1196-1202. PubMed ID: 31021657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical performance of the Food and Drug Administration-Approved high-risk HPV test for the detection of high-grade cervicovaginal lesions.
    Zhou H; Mody RR; Luna E; Armylagos D; Xu J; Schwartz MR; Mody DR; Ge Y
    Cancer Cytopathol; 2016 May; 124(5):317-23. PubMed ID: 26774025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective and retrospective review of gynecologic cytopathology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 2.
    Brainard JA; Birdsong GG; Elsheikh TM; Hartley DA; Naik K; Neal MH; Souers RJ; Henry MR
    Arch Pathol Lab Med; 2013 Feb; 137(2):175-82. PubMed ID: 23368859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring and ordering practices for human papillomavirus in cervical cytology: findings from the College of American Pathologists Gynecologic Cytopathology Quality Consensus Conference working group 5.
    Booth CN; Bashleben C; Filomena CA; Means MM; Wasserman PG; Souers RJ; Henry MR
    Arch Pathol Lab Med; 2013 Feb; 137(2):214-9. PubMed ID: 23368863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus testing and reporting rates in 2012: results of a College of American Pathologists national survey.
    Zhao C; Moriarty AT; Ghofrani M; Husain M; Tambouret RH; Laucirica R; Laser A; Fischer A; Ocal IT; Souers RJ; Russell DK; Fan F; Crothers BA
    Arch Pathol Lab Med; 2015 Jun; 139(6):757-61. PubMed ID: 25436905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in Cervical Cytology Screening and Reporting Practices: Results From the College of American Pathologists 2011 PAP Education Supplemental Questionnaire.
    Crothers BA; Darragh TM; Tambouret RH; Nayar R; Barkan GA; Zhao C; Booth CN; Padmanabhan V; Tabatabai ZL; Souers RJ; Thomas N; Wilbur DC; Moriarty AT
    Arch Pathol Lab Med; 2016 Jan; 140(1):13-21. PubMed ID: 26046490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of monitoring human papillomavirus DNA results for Papanicolaou tests diagnosed as atypical squamous cells of undetermined significance: a College of American Pathologists Q-Probes study of 68 institutions.
    Tworek JA; Jones BA; Raab S; Clary KM; Walsh MK
    Arch Pathol Lab Med; 2007 Oct; 131(10):1525-31. PubMed ID: 17922588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Practices of participants in the college of american pathologists interlaboratory comparison program in cervicovaginal cytology, 2006.
    Eversole GM; Moriarty AT; Schwartz MR; Clayton AC; Souers R; Fatheree LA; Chmara BA; Tench WD; Henry MR; Wilbur DC
    Arch Pathol Lab Med; 2010 Mar; 134(3):331-5. PubMed ID: 20196659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the college of American pathologists interlaboratory comparison program in cervicovaginal cytology.
    Davey DD; Woodhouse S; Styer P; Stastny J; Mody D
    Arch Pathol Lab Med; 2000 Feb; 124(2):203-11. PubMed ID: 10656727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus testing and reporting rates: practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Gynecologic Cytology in 2006.
    Moriarty AT; Schwartz MR; Eversole G; Means M; Clayton A; Souers R; Fatheree L; Tench WD; Henry M; Wilbur DC
    Arch Pathol Lab Med; 2008 Aug; 132(8):1290-4. PubMed ID: 18684028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristic findings of cervical Papanicolaou tests from transgender patients on androgen therapy: Challenges in detecting dysplasia.
    Adkins BD; Barlow AB; Jack A; Schultenover SJ; Desouki MM; Coogan AC; Weiss VL
    Cytopathology; 2018 Jun; 29(3):281-287. PubMed ID: 29488269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bethesda 2001 implementation and reporting rates: 2003 practices of participants in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology.
    Davey DD; Neal MH; Wilbur DC; Colgan TJ; Styer PE; Mody DR
    Arch Pathol Lab Med; 2004 Nov; 128(11):1224-9. PubMed ID: 15504056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytopathology laboratory improvement programs of the College of American Pathologists: Laboratory Accreditation Program (CAP LAP) and Performance Improvement Program in Cervicovaginal Cytology (CAP PAP).
    Nielsen ML
    Arch Pathol Lab Med; 1997 Mar; 121(3):256-9. PubMed ID: 9111112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervical cancer screening with both human papillomavirus and Papanicolaou testing vs Papanicolaou testing alone: what screening intervals are physicians recommending?
    Saraiya M; Berkowitz Z; Yabroff KR; Wideroff L; Kobrin S; Benard V
    Arch Intern Med; 2010 Jun; 170(11):977-85. PubMed ID: 20548011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
    Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
    J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.